Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.3350
+0.0020 (0.60%)
At close: Jul 14, 2025, 4:00 PM
0.3300
-0.0050 (-1.49%)
After-hours: Jul 14, 2025, 7:58 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $8.40 million as of July 14, 2025. Its market cap has decreased by -87.97% in one year.
Market Cap
8.40M
Enterprise Value
7.73M
1-Year Change
-87.97%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $8.40M, a decrease of -87.28%. That is a compound annual growth rate of -63.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 8.35M | -68.59% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |